IgNova Files Patent Application on Antibody Against COVID-19
VISBEK, Germany, June 24, 2020 /PRNewswire-AsiaNet/ -- IgNova announced today that it has filed a patent application covering the use of passive immunization to control SARS-CoV-2 infection in humans. IgNova, a biopharmaceutical R&D start up, researches technology based on specific egg immunoglobulins...
Authors: LATEST ASIANET NEWS RELEASES